Company / Interest Expense
Progyny Interest Expense History
FY2017-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$121.0K
FY2022
5-year range
$121.0K / $461.0K
FY2018-FY2022
Trend
-73.8%
vs FY2021
Sector context
#44 of 43
Health Care
What the data says
Among 43 Health Care companies, Progyny is in the top -2% for interest expense.
Based on SEC 10-K filings.
$121,000 in FY2022.
Remained stable around $121,000 over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top -2% in Health CareTop -2% of 43This company $121.0K Sector average $324.8M
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2022, interest expense decreased 73.8% year-over-year.
- Ranks #44 out of 43 companies in the Health Care sector.
- Peak interest expense was recorded in FY2021.
- Lowest interest expense in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 3.62 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $121.0K | -73.8% |
| FY2021 | $461.0K | +281.0% |
| FY2020 | $121.0K | +308.6% |
| FY2019 | -$58.0K | +88.3% |
| FY2018 | -$497.0K | +32.8% |
| FY2017 | -$740.0K | - |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026